These persistent differences in susceptibility to EBV-associated cHL among human populations might be partially explained by polymorphic genetic systems that show ethnic variation in the rates of allelic prevalence, such as HLA-E and HLA-A. Here, HLA-A is linked to classic Hodgkin lymphoma.